The U.S. Food and Drug Administration last Friday granted approval for Besremi (ropeginterferon alfa-2b-njft) injection for treatments of...

Johnson & Johnson said it plans to spin off its consumer health unit that markets Baby Powder and Listerine to concentrate on...

Biotech is one of the most expensive industries in the world, and prospectively it will keep advancing as the world knows new age of...

Merck (NYSE: MRK) referred to as MSD outside U.S. and Canada, and Ridgeback Biotherapeutics last Friday made it known that Molnupiravir...

Exscientia plc, an Artificial Intelligence firm focused on discovering, designing and developing the highest quality medications in the...

2021 has already witnessed many eventful FDA approvals. Not even the pandemic could stop biopharma’s historic ability to push prospects...

Osaka-based pharma, Takeda Pharmaceutical Company Limited (“Takeda”) on Wednesday announced the U.S. Food and Drug Administration (FDA)’s...

Life sciences venture firm TP on Wednesday announced the launch of Replicate Bioscience in a bid to replicating the success RNA...

The trial of the founder of Theranos, Elizabeth Holmes began on Wednesday in federal court in San Jose, California. Elizabeth who dropped...

FDA approves first of its kind indication for chronic sleep disorder treatment The U.S. Food and Drug Administration on August 12 grants...

California-based RenovoRx, Inc. (NASDAQ: RNXT) has filed for offering up to 1.85 million units of securities in an initial public...

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical firm into discovery, development and commercialization of antibody-based...

On August 6, 2021, the U.S. Food and Drug Administration announced it has approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous...

Ring Therapeutics, a life sciences firm established by Flagship Pioneering to transform gene therapy with its commensal virome platform,...

Amgen and Teneobio on July 27, 2021 announced they had reached an agreement which will see Amgen acquire Teneobio, a privately held,...

The U.S. Food and Drug Administration on July 28 announced the approval of the first interchangeable biosimilar insulin product aimed at...

The U.S. securities regulator in an exclusive report released on July 30 says it will not allow Chinese companies to undertake...

Is there ample proof that Biogen’s new Alzheimer’s med Aduhelm is beneficial to patients, physicians and society beyond the existing...

FibroGen and AstraZeneca have been pushing for a better heart safety profile for their likely top-of-the-shelf anemia med roxadustat...

European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary...